Syncom Formulation (India) (NSE:SYNCOMF) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Syncom Formulation (India)'s Free Cash Flow for the three months ended in Dec. 2023 was ₹0 Mil. Syncom Formulation (India)'s Revenue for the three months ended in Dec. 2023 was ₹651 Mil. Therefore, Syncom Formulation (India)'s FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Syncom Formulation (India)'s current FCF Yield % is -0.82%.

The historical rank and industry rank for Syncom Formulation (India)'s FCF Margin % or its related term are showing as below:

NSE:SYNCOMF' s FCF Margin % Range Over the Past 10 Years
Min: -5.35 Med: 2.18 Max: 8.74
Current: -4.07

During the past 13 years, the highest FCF Margin % of Syncom Formulation (India) was 8.74%. The lowest was -5.35%. And the median was 2.18%.

NSE:SYNCOMF's FCF Margin % is ranked worse than
58.02% of 1029 companies
in the Drug Manufacturers industry
Industry Median: -0.47 vs NSE:SYNCOMF: -4.07

Syncom Formulation (India) FCF Margin % Historical Data

The historical data trend for Syncom Formulation (India)'s FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) FCF Margin % Chart

Syncom Formulation (India) Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

2.38

2.06

-1.97

2.30

-4.54

Syncom Formulation (India) Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Syncom Formulation (India)'s FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syncom Formulation (India)'s FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s FCF Margin % distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s FCF Margin % falls into.

Syncom Formulation (India) FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Syncom Formulation (India)'s FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-101.054	/	2224.861
	=	-4.54 %

Syncom Formulation (India)'s FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	651.395
	=	0.00 %

Syncom Formulation (India) FCF Margin % Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Syncom Formulation (India) (NSE:SYNCOMF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » FCF Margin %

Traded in Other Exchanges

524470:India

Address

207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018

Website

https://www.sfil.in

Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (NSE:SYNCOMF) Headlines

No Headlines